Prions: Protein Aggregation and Infectious Diseases - Physiological ...

1150 ADRIANO AGUZZI AND ANNA MARIA CALELLA
tions between homologous PrP isoforms in scrapie prion replication.
Cell 63: 673–686, 1990.
413. Puckett C, Concannon P, Casey C, Hood L. Genomic structure
of the human prion protein gene. Am J Hum Genet 49: 320–329,
1991.
414. Radovanovic I, Braun N, Giger OT, Mertz K, Miele G, Prinz M,
Navarro B, Aguzzi A. Truncated prion protein and Doppel are
myelinotoxic in the absence of oligodendrocytic PrPC. J Neurosci
25: 4879–4888, 2005.
415. Raeber AJ, Klein MA, Frigg R, Flechsig E, Aguzzi A, Weissmann
C. PrP-dependent association of prions with splenic but not
circulating lymphocytes of scrapie-infected mice. EMBO J 18:
2702–2706, 1999.
416. Raeber AJ, Sailer A, Hegyi I, Klein MA, Rülicke T, Fischer M,
Brandner S, Aguzzi A, Weissmann C. Ectopic expression of
prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout
mice is insufficient to sustain prion replication. Proc Natl Acad
Sci USA 96: 3987–3992, 1999.
417. Rane NS, Kang SW, Chakrabarti O, Feigenbaum L, Hegde RS.
Reduced translocation of nascent prion protein during ER stress
contributes to neurodegeneration. Dev Cell 15: 359–370, 2008.
418. Raymond CR, Aucouturier P, Mabbott NA. In vivo depletion of
CD11c cells impairs scrapie agent neuroinvasion from the intestine.
J Immunol 179: 7758–7766, 2007.
419. Raymond GJ, Bossers A, Raymond LD, O’Rourke KI, Mc-
Holland LE, Bryant PK, Miller MW, Williams ES, Smits M,
Caughey B. Evidence of a molecular barrier limiting susceptibility
of humans, cattle and sheep to chronic wasting disease. EMBO J
19: 4425–4430, 2000.
420. Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R,
Kopito RR. Cytoplasmic penetration and persistent infection of
mammalian cells by polyglutamine aggregates. Nat Cell Biol 11:
219–225, 2009.
421. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R,
Wüthrich K. NMR structure of the mouse prion protein domain
PrP(121-231). Nature 382: 180–182, 1996.
422. Riek R, Hornemann S, Wider G, Glockshuber R, Wüthrich K.
NMR characterization of the full-length recombinant murine prion
protein, mPrP(23-231). FEBS Lett 413: 282–288, 1997.
423. Riesner D. Transmissible spongiform encephalopathies: the prion
theory–background and basic information. Contrib Microbiol 11:
1–13, 2004.
424. Riesner D, Kellings K, Wiese U, Wulfert M, Mirenda C,
Prusiner SB. Prions and nucleic acids: search for “residual” nucleic
acids and screening for mutations in the PrP-gene. Dev Biol
Stand 80: 173–181, 1993.
425. Rivera-Milla E, Stuermer CA, Malaga-Trillo E. An evolutionary
basis for scrapie disease: identification of a fish prion mRNA.
Trends Genet 19: 72–75, 2003.
426. Roberts GW, Lofthouse R, Allsop D, Landon M, Kidd M,
Prusiner SB, Crow TJ. CNS amyloid proteins in neurodegenerative
diseases. Neurology 38: 1534–1540, 1988.
427. Rossi D, Cozzio A, Flechsig E, Klein MA, Rulicke T, Aguzzi A,
Weissmann C. Onset of ataxia and Purkinje cell loss in PrP null
mice inversely correlated with Dpl level in brain. EMBO J 20:
694–702, 2001.
428. Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey
DJ, Wormald MR, Serban H, Prusiner SB, Kobata A, Dwek RA.
Glycosylation differences between the normal and pathogenic
prion protein isoforms. Proc Natl Acad Sci USA 96: 13044–13049,
1999.
429. Ruegger J, Stoeck K, Amsler L, Blaettler T, Zwahlen M,
Aguzzi A, Glatzel M, Hess K, Eckert T. A case-control study of
sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential
risk factors with regard to an increased CJD incidence in the
years 2001–2004. BMC Public Health 9: 18, 2009.
430. Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol
5: 39–47, 2007.
431. Rutishauser D, Mertz KD, Moos R, Brunner E, Rulicke T,
Calella AM, Aguzzi A. The comprehensive native interactome of
a fully functional tagged prion protein. PLoS ONE 4: e4446, 2009.
432. Saa P, Castilla J, Soto C. Presymptomatic detection of prions in
blood. Science 313: 92–94, 2006.
Physiol Rev VOL 89 OCTOBER 2009 www.prv.org
433. Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious
prions by automated protein misfolding cyclic amplification. J Biol
Chem 281: 35245–35252, 2006.
434. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological
prion protein by cyclic amplification of protein misfolding.
Nature 411: 810–813, 2001.
435. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. Conformational
transitions, dissociation, unfolding of scrapie amyloid (prion) protein.
J Biol Chem 268: 20276–20284, 1993.
436. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. Thermal stability
and conformational transitions of scrapie amyloid (prion) protein
correlate with infectivity. Protein Sci 2: 2206–2216, 1993.
437. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen
F, Prusiner S. Eight prion strains have PrP Sc molecules with
different conformations. Nat Med 4: 1157–1165, 1998.
438. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen
FE, Prusiner SB. Eight prion strains have PrP(Sc) molecules with
different conformations. Nat Med 4: 1157–1165, 1998.
439. Sailer A, Büeler H, Fischer M, Aguzzi A, Weissmann C. No
propagation of prions in mice devoid of PrP. Cell 77: 967–968, 1994.
440. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu
K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S,
Okada H, Hasegawa S, Miyamoto T, Noda T. Loss of cerebellar
Purkinje cells in aged mice homozygous for a disrupted PrP gene.
Nature 380: 528–531, 1996.
441. Sakudo A, Lee DC, Saeki K, Nakamura Y, Inoue K, Matsumoto
Y, Itohara S, Onodera T. Impairment of superoxide dismutase
activation by N-terminally truncated prion protein (PrP) in PrPdeficient
neuronal cell line. Biochem Biophys Res Commun 308:
660–667, 2003.
442. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N,
Sánchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki
J, Hess K, Bodemer M, Slivarichová D, Saiz A, Calero M,
Ingrosso L, Knight R, Janssens ACJW, van Duijn C, Zerr I.
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
Neurology 67: 637–643, 2006.
443. Schreuder BE, Vankeulen LJ, Vromans ME, Langeveld JP,
Smits MA. Preclinical test for prion diseases. Nature 381: 563,
1996.
444. Scoazec JY, Krolak-Salmon P, Casez O, Besson G, Thobois S,
Kopp N, Perret-Liaudet A, Streichenberger N. Quinacrine-induced
cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease.
Ann Neurol 53: 546–547, 2003.
445. Scott JR, Foster JD, Fraser H. Conjunctival instillation of
scrapie in mice can produce disease. Vet Microbiol 34: 305–309,
1993.
446. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Waelchli
M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway
D, Prusiner SB. Transgenic mice expressing hamster prion protein
produce species-specific scrapie infectivity and amyloid
plaques. Cell 59: 847–857, 1989.
447. Scott M, Groth D, Foster D, Torchia M, Yang SL, DeArmond
SJ, Prusiner SB. Propagation of prions with artificial properties in
transgenic mice expressing chimeric PrP genes. Cell 73: 979–988,
1993.
448. Seeger H, Heikenwalder M, Zeller N, Kranich J, Schwarz P,
Gaspert A, Seifert B, Miele G, Aguzzi A. Coincident scrapie
infection and nephritis lead to urinary prion excretion. Science 310:
324–326, 2005.
449. Sekercioglu CH. Prion diseases and a penchant for brains. Science
305: 342–343, 2004.
450. Sethi S, Lipford G, Wagner H, Kretzschmar H. Postexposure
prophylaxis against prion disease with a stimulator of innate immunity.
Lancet 360: 229–230, 2002.
451. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson
NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA,
Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. Amyloid-beta
protein dimers isolated directly from Alzheimer’s brains impair
synaptic plasticity and memory. Nat Med 14: 837–842, 2008.
452. Shlomchik MJ, Radebold K, Duclos N, Manuelidis L. Neuroinvasion
by a Creutzfeldt-Jakob disease agent in the absence of B
cells and follicular dendritic cells. Proc Natl Acad Sci USA 98:
9289–9294, 2001.